- Report
- January 2024
- 229 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Report
- March 2024
- 181 Pages
Global
From €3226EUR$3,374USD£2,765GBP
€3585EUR$3,749USD£3,072GBP
- Report
- March 2024
- 196 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Report
- January 2024
- 200 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 200 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- October 2023
- 150 Pages
Global
From €4638EUR$4,850USD£3,974GBP
- Report
- May 2023
- 150 Pages
Global
From €4638EUR$4,850USD£3,974GBP
- Report
- October 2023
- 175 Pages
Global
From €4686EUR$4,900USD£4,015GBP
- Report
- February 2024
- 180 Pages
Global
From €3442EUR$3,600USD£2,950GBP
- Report
- January 2024
- 200 Pages
Global
From €3968EUR$4,150USD£3,401GBP
- Report
- December 2023
- 312 Pages
Global
From €3870EUR$4,047USD£3,316GBP
€4300EUR$4,497USD£3,685GBP
- Report
- March 2024
- 93 Pages
Global
From €5355EUR$5,600USD£4,589GBP
- Report
- February 2024
- 175 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- January 2024
- 164 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- February 2024
- 118 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- November 2023
- 100 Pages
Global
From €3820EUR$3,995USD£3,274GBP
- Report
- June 2023
- 361 Pages
Global
From €5259EUR$5,500USD£4,507GBP
- Report
- February 2024
- 442 Pages
Global
From €5259EUR$5,500USD£4,507GBP
- Report
- March 2024
- 199 Pages
Global
From €3226EUR$3,374USD£2,765GBP
€3585EUR$3,749USD£3,072GBP
- Report
- March 2024
- 605 Pages
Global
From €5212EUR$5,450USD£4,466GBP
The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more